Paul V Maier, Director, on August 28, 2026, sold 50,000 shares in Eton Pharmaceuticals (ETON) for $2,953,572. Following the Form 4 filing with the SEC, Maier has control over a total of 59,745 common shares of the company, with 59,745 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1710340/000143774926029196/xslF345X05/rdgdoc.xml
Olivier Le Peuch, Director, Chief Executive Officer, on August 27, 2026, sold 5,000 shares in SLB (SLB) for $275,000. Following the Form 4 filing with the SEC, Le Peuch has control over a total of 1,336,328 common shares of the company, with 1,336,328 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/87347/000008734726000118/xslF345X05/form4.xml
Elizabeth Karpinski Vonne, Executive Vice President, General Counsel, on August 27, 2026, sold 907 shares in Advanced Energy Industries (AEIS) for $263,075. Following the Form 4 filing with the SEC, Vonne has control over a total of 9,805 common shares of the company, with 9,805 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/927003/000192314926000008/xslF345X05/ownership.xml
Brian C Cornell, Director, Executive Officer, on August 25, 2026, sold 50,000 shares in Target (TGT) for $8,177,780. Following the Form 4 filing with the SEC, Cornell has control over a total of 278,503 common shares of the company, with 134,733 shares held directly and 143,770 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/27419/000128870926000013/xslF345X05/wk-form4_1787866415.xml